A Call for the FDA to Impose a Ban on Xarelto
The Goal. To protect more patients from the potential harm and side effects of Xarelto.
The Problem. Patients who have undergone heart surgeries or hip replacement surgeries are told by their physicians to take Xarelto, a famous blood thinner commonly prescribed not only in the abovementioned cases but also for patients who suffer from atrial fibrillation. Xarelto is an FDA-approved treatment for DVT, abnormal blood clotting, and pulmonary embolism.
But despite these advantages of using the drug, there is growing debate in the medical industry on whether to continue the use of Xarelto, considering the many serious side effects of the drug. Patients who take Xarelto can experience internal bleeding, heart attacks, spinal hematomas, and death. Another popular name is Warfarin, to which there is an antidote. Xarelto, however, does not.
The Solution. There is no antidote to Xarelto. Although the FDA approved the first antidote in 2018, it’s not easy to conclude that the antidote really works effectively, given the short period of time the tests were conducted to test the effectivity of the antidote. Therefore, even with the approved “antidote,” there is still no guarantee that serious and fatal bleeding can be stopped.
Patients spend money on their medications to better the quality of their health but what we’re seeing is the opposite. Drugwatcher understands the sentiments of each patient suffering from Xarelto’s side effects. You can click here to discover how Xarelto cases and lawsuits are expertly handled by the team of experts at Drugwatcher.
Sign this petition now!
Petition to: FDA